Last reviewed · How we verify
Aerobic Gram-Negative Bacteremia
Approved treatments
- Azactam · Bristol-Myers Squibb
Aztreonam inhibits bacterial cell wall synthesis, acting as a bactericidal agent.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Aerobic Gram-Negative Bacteremia patent landscape — cliff calendar, originator estates, attackable patents
- Aerobic Gram-Negative Bacteremia treatment landscape brief
- Aerobic Gram-Negative Bacteremia treatment updates RSS
Frequently asked questions about Aerobic Gram-Negative Bacteremia
What drugs treat Aerobic Gram-Negative Bacteremia?
Tracked treatments include Azactam.
What is the treatment for Aerobic Gram-Negative Bacteremia?
Standard treatment for Aerobic Gram-Negative Bacteremia includes Azactam. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Aerobic Gram-Negative Bacteremia patent cliff · Aerobic Gram-Negative Bacteremia CI report
- Treatment: Azactam · Bristol-Myers Squibb
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing